Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carvedilol and the kidney.

A G Dupont1

  • 1Department of Internal Medicine, Academic Hospital, University of Brussels.

The Clinical Investigator
|January 1, 1992
PubMed
Summary

Carvedilol, a unique antihypertensive, preserves renal blood flow and function, unlike some beta-blockers. Studies show it effectively controls hypertension while maintaining kidney health in various models and patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving management of intravenous maintenance fluids in the emergency department of a university hospital.

European review for medical and pharmacological sciences·2024
Same author

Clinical trials with direct oral anticoagulants for stroke prevention in atrial fibrillation: how representative are they for real life patients?

European journal of clinical pharmacology·2016
Same author

Relationship between pre-stroke cardiovascular medication use and stroke severity.

European journal of clinical pharmacology·2015
Same author

Comparison of two approaches of INR-follow-up and determinants of INR-stability.

Acta clinica Belgica·2015
Same author

Pharmacists' role in handling problems with prescriptions for antithrombotic medication in Belgian community pharmacies.

International journal of clinical pharmacy·2015
Same author

Physician's expectations regarding prescribing clinical decision support systems in a Belgian hospital.

Acta clinica Belgica·2014

Area of Science:

  • Pharmacology
  • Nephrology
  • Cardiovascular Medicine

Background:

  • Antihypertensive drugs impact renal hemodynamics and function differently.
  • Nonselective beta-blockers like propranolol can reduce renal blood flow and glomerular filtration rate.
  • Carvedilol possesses unique properties including beta-blockade, alpha 1-adrenoceptor blockade, and potential calcium antagonism.

Purpose of the Study:

  • To investigate the renal effects of carvedilol compared to other antihypertensives.
  • To evaluate carvedilol's impact on renal hemodynamics, function, and sodium balance.
  • To assess carvedilol's efficacy in preserving renal function during hypertension treatment.

Main Methods:

  • Animal studies involving intrarenal infusion and intravenous administration in dogs and spontaneously hypertensive rats (SHR).
  • Evaluation in a rat model of progressive hypertensive renal disease.
  • Clinical assessment in patients with essential hypertension.

Main Results:

  • Carvedilol induced renal vasodilation and preserved renal blood flow in dogs, contrasting with propranolol's vasoconstriction and sodium retention.
  • Carvedilol did not cause sodium retention in SHR models, unlike labetalol.
  • Carvedilol effectively controlled hypertension and preserved renal function in hypertensive rat models.
  • In hypertensive patients, carvedilol reduced renal vascular resistance, maintained renal autoregulation, and preserved renal function during chronic treatment.

Conclusions:

  • Carvedilol demonstrates a favorable renal profile compared to traditional beta-blockers.
  • Renal perfusion and function are well-maintained during both acute and chronic carvedilol treatment.
  • Carvedilol is a promising antihypertensive agent for patients concerned about renal health.

Related Experiment Videos